Avantor, Inc. (NYSE:AVTR) Receives $10.47 Consensus PT from Analysts

Shares of Avantor, Inc. (NYSE:AVTR) have been assigned an average recommendation of “Reduce” from the seventeen brokerages that are currently covering the firm, MarketBeat reports. Three investment analysts have rated the stock with a sell rating, twelve have issued a hold rating and two have given a buy rating to the company. The average 12-month target price among brokers that have issued ratings on the stock in the last year is $10.4688.

Several research analysts recently commented on the stock. Royal Bank Of Canada began coverage on shares of Avantor in a report on Thursday, May 14th. They issued a “sector perform” rating and a $9.00 price target on the stock. Wall Street Zen upgraded shares of Avantor from a “hold” rating to a “buy” rating in a research note on Saturday, June 27th. Zacks Research raised shares of Avantor from a “strong sell” rating to a “hold” rating in a research report on Thursday, April 30th. Wolfe Research lowered shares of Avantor to an “underperform” rating and set a $7.00 price objective for the company. in a research report on Monday, June 1st. Finally, Citigroup cut their target price on shares of Avantor from $11.00 to $9.00 and set a “neutral” rating on the stock in a research note on Thursday, April 30th.

Insider Buying and Selling at Avantor

In related news, Director Gregory T. Lucier purchased 10,000 shares of the stock in a transaction that occurred on Friday, May 8th. The stock was purchased at an average cost of $8.32 per share, for a total transaction of $83,200.00. Following the acquisition, the director owned 60,000 shares in the company, valued at approximately $499,200. This trade represents a 20.00% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Simon Dingemans bought 25,000 shares of the company’s stock in a transaction that occurred on Friday, May 1st. The shares were bought at an average price of $8.14 per share, for a total transaction of $203,500.00. Following the completion of the acquisition, the director owned 25,000 shares in the company, valued at approximately $203,500. This trade represents a ∞ increase in their position. The SEC filing for this purchase provides additional information. 0.28% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the company. Parallel Advisors LLC boosted its position in Avantor by 21.4% in the 1st quarter. Parallel Advisors LLC now owns 8,452 shares of the company’s stock valued at $66,000 after buying an additional 1,491 shares during the last quarter. Verus Capital Partners LLC purchased a new stake in shares of Avantor during the first quarter worth about $111,000. Bank of America Corp DE lifted its stake in shares of Avantor by 24.3% in the first quarter. Bank of America Corp DE now owns 7,067,563 shares of the company’s stock worth $55,410,000 after acquiring an additional 1,382,320 shares in the last quarter. Edgestream Partners L.P. lifted its stake in shares of Avantor by 21.8% in the first quarter. Edgestream Partners L.P. now owns 418,095 shares of the company’s stock worth $3,278,000 after acquiring an additional 74,728 shares in the last quarter. Finally, ADAR1 Capital Management LLC boosted its holdings in Avantor by 14.3% in the first quarter. ADAR1 Capital Management LLC now owns 80,000 shares of the company’s stock valued at $627,000 after purchasing an additional 10,000 shares during the last quarter. 95.08% of the stock is owned by institutional investors and hedge funds.

Avantor Stock Performance

Shares of NYSE:AVTR opened at $10.05 on Monday. The firm has a market capitalization of $6.87 billion, a PE ratio of -12.41, a P/E/G ratio of 5.74 and a beta of 0.94. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.17. The business has a 50-day moving average of $8.80 and a two-hundred day moving average of $9.47. Avantor has a 12 month low of $7.26 and a 12 month high of $15.93.

Avantor (NYSE:AVTR) last released its quarterly earnings data on Wednesday, April 29th. The company reported $0.17 EPS for the quarter, topping analysts’ consensus estimates of $0.16 by $0.01. Avantor had a positive return on equity of 9.95% and a negative net margin of 8.42%.The company had revenue of $1.58 billion for the quarter, compared to the consensus estimate of $1.54 billion. During the same period last year, the business posted $0.23 EPS. The company’s quarterly revenue was up .0% compared to the same quarter last year. As a group, research analysts forecast that Avantor will post 0.79 earnings per share for the current year.

Avantor Company Profile

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.